Acuta Capital Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-134,000
Closed -$5.49M 39
2019
Q3
$5.49M Buy
134,000
+55,000
+70% +$2.25M 3.96% 8
2019
Q2
$3.72M Buy
+79,000
New +$3.72M 1.32% 22
2018
Q2
Hold
0
40
2018
Q1
Hold
0
39
2017
Q4
Hold
0
37